TABLE 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Myrto Moutafi,Georgia-Angeliki Koliou,George Papaxoinis,Panagiota Economopoulou,Ioannis Kotsantis,Maria Gkotzamanidou,Maria Anastasiou,Dimitrios Pectasides,Efthymios Kyrodimos,Alexander Delides,Evangelos Giotakis,Nikolaos G. Papadimitriou,Ioannis G. Panayiotides,Christos Perisanidis,Aileen I. Fernandez,Vasiliki Xirou,Christos Poulios,Eleni Gagari,Vesal Yaghoobi,Niki Gavrielatou,Saba Shafi,Thazin Nwe Aung,Andromachi Kougioumtzopoulou,Vassilis Kouloulias,Konstantinos Palialexis,Stavros Gkolfinopoulos,Areti Strati,Evi Lianidou,George Fountzilas,David L. Rimm,Periklis G. Foukas,Amanda Psyrri openalex（2023）
Key words
Cancer Therapy,Olaparib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper